Pesquisar...
Close this search box.
A Primeira Academic Research Organization da América Latina

Pesquisa Clínica com Ética e Qualidade

Há 15 anos liderando projetos multicêntricos internacionais na América Latina.

clinical research institute bcri20

Operações Clínicas

Como uma ARO (Academic Research Organization) atuamos em todas as etapas de um estudo clínico: planejamento de estudo, desenvolvimento do protocolo, análise estatística, liderança acadêmica, publicações, entre outros.

Saiba mais »

Educação

O BCRI amplia sua atuação educativa, percebendo demandas ou gaps na formação, buscando apoios significativos para oferecer formações que atualizem o profissional com o que há de mais avançado cientificamente.

Saiba mais »

Em 2022, o Brazilian Clinical Research Institute (BCRI) e a MDHealth uniram forças para criar a Galen Academy, uma plataforma de ensino para médicos e profissionais de saúde, oferecendo programas de pós-graduação e cursos especializados de alta qualidade.

Essa parceria não só fortaleceu nosso compromisso com a excelência acadêmica, mas também nos posicionou como o maior ecossistema educacional em saúde da América Latina, com a integração das marcas BCRI, MDHealth, Galen Academy, Hemomeeting, NetMD e MDlife.

Impulsionados pela vontade de impulsionar a evolução da medicina e promover ideias inovadoras, agora celebramos uma nova era como Med.IQ. Nossa trajetória foi guiada pelos valores de excelência, compromisso e paixão pelo conhecimento.

A Med.IQ representa a fusão dessas instituições e se destaca como a primeira healthtech knowledge da América Latina. Esta transformação reflete nosso constante desejo de progresso e mudança positiva na área da saúde.

 

Acreditamos no poder da colaboração e na sinergia da inteligência coletiva. Juntos, estamos moldando um futuro mais promissor para a saúde, baseado em inovação, excelência e um compromisso firme com o bem-estar de todos.

quad med.iq

Depoimentos

"From the Scandinavian and European perspective we are very impressed by the rapid development of BCRI as a new hub for clinical trials in cardiovascular diseases in Brazil and South America. We very much look forward to a continuing and expanding collaboration in our mutual efforts to promote cardiovascular health both locally and globally."
Lars WallentinProfessor Cardiology, Director UCR
“The development of the BCRI reflects the growing importance of Brazil as a contributor to the International Clinical Trials arena. Institutes like the BCRI will lead the way as Brazil assumes its position as a leading force in the generation of evidence that guides the care of patients.”
Mark CrowtherMD, MSc, FRCPC
"The growth and success of the BCRI are indeed remarkable. The ongoing efforts of Dr. Renato Lopes and his colleagues have not only advanced the cause of clinical investigation, but have also brought important capabilities, new infrastructure and cutting edge medical therapy to the Brazilian healthcare system."
Prof. David A. Garcia
“The BCRI is an academic research organization in Brazil that has been the official extension of the Duke Clinical Research Institute in South America.”
Prof. Dr. Renato Delascio Lopes
“O BCRI é uma ideia maravilhosa porque permite uma integração de grupos de pesquisadores daqui do Brasil com investigadores de todo o mundo."
Prof. Dr. Robert Harrington
“We are very proud of the growth of the BCRI over the past several years. We are highly committed to our collaboration with the BCRI to help carry out transformative clinical research in South America.”
Prof. Eric D. Peterson
“The expansion of this unique clinical research institute in Sao Paulo - Brazil has been having a significant impact on the conduction of large international trials in the field of cardiovascular diseases. Many academic research organizations both in Europe and North-America are eager to continue working with the BCRI.”
Prof. Frans Van de Werf
“I have been delighted to see the growth of BRCI under the visionary leadership of Dr Renato Lopes. Clearly the Institute is making major and important contributions to the International research community at multiple levels as well as to Brazil which will impact on the health of Brazilian people. Of most importance is the development of young people with energy and enthusiasm for research under the guidance of Dr Lopes. This can only bode well for the future of Brazil.”
Prof. Harvey White
“BCRI is a valued partner and provides a much needed perspective towards achieving our global goal of enhancing cardiovascular health. We appreciate the vigorous collaboration provided by Renato Lopes and his colleagues in STREAM and look forward to future creative efforts that together will bring us closer to our goal”
Prof. Paul W. Armostrong
“The future of clinical research will depend upon global collaboration using modern informatics and study designs, linked to outstanding clinical investigators. The BCRI is a leader in this effort.”
Prof. Robert M. CaliffCEO
“BCRI has the regulatory and clinical expertise necessary to conduct high-risk trials sponsored by the government agencies (e.g., NIH) for labeling.”
Professor Danny Benjamin, MD, PHD
“The growth of the BCRI since its inception just 5 (is this correct?) years ago has been impressive. In addition to BCRI's positive contributions in the conduct of clinical research projects and the dissemination of the results, the BCRI provides an important fertile ground for the training and development of clinical researchers.”
Sharon Karnash
“International collaboration between dedicated high quality academic research centers is key in order to conduct global high impact clinical research resulting in improved health care. BCRI under the leadership of Dr. Lopes is a great example of how fruitful such a collaboration can be.”
Stefan James

Pesquisa Clínica com Ética e Qualidade

BCRI

Localização

Contato

Linkedin Instagram